Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Conbercept timing before vitrectomy in proliferative diabetic retinopathy
ChiCTR-IIR-17014160Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2017
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of conbercept in diabetic retinopathy (DR) (6 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Vitreous VEGF concentration. Started Jun 2017; status: recruiting.
02
Drugs
conbercept
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on ChiCTR-IIR-17014160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17014160.